US FDA Warns Supplement Own Labeler About Reliance On Manufacturer For Compliance

Revival Products’ GMP deficiencies concerned work and training of its quality control staff, including failing to document review and approval for release of any packaged and labeled supplement for distribution and destroying returned products without review.

Stamp with word warning inside,vector illustration

More from Regulation

More from Policy & Regulation